Gastroparesis Drugs Market – ETX Pharma’s lead drug candidates, ETX-101 and ETX-301

Recent Developments

ETX Pharma Inc. is a biotech Company with an aggressive drug pipeline. ETX-101 is a first-in-class GI therapeutic and is differentiated by oral administration and, unlike competitive drugs, has a long safety record as an FDA approved drug. It targets the root cause of gastroparesis. ETX-301 is a modifying drug to treat severe diabetic gastroparesis and functional dyspepsia.

To know more read: https://www.marketdataforecast.com/market-reports/global-gastroparesis-drugs-market-5254/

Market Segmentations

Market data Forecast published a report named Gastroparesis Drugs Market. It is valued at USD 5.22 Billion in 2018, and it expected to reach USD 6.6 Billion by 2023 with a CAGR of 4.8%.

Report is segmented by

Drug Type

Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Disease Class

Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Based on drug type, prokinetic agents accounted for the largest share of the market. Under the disease class, Idiopathic Gastroparesis is leading the market.

Geographical Segmentation

Based on geography the market is analyzed into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America accounted for the largest market share and Asia Pacific is expected to grow at a highest rate.

Key market players in the market are:

Allergan, Plc.
Abbott Laboratories
AstraZeneca Plc.
Cadila Pharmaceuticals Ltd.
View sample and decide: https://www.marketdataforecast.com/market-reports/global-gastroparesis-drugs-market-5254/request-sample

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategically activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank Film Nagar Branch, B 44, Rd no 3, Journalist Colony,
Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626

This release was published on openPR.